Yale researchers have found that it may be possible to provide personalized treatment for chronic pain, according to a Yale News report.
Research into mutations in a rare, agonizing and previously thought untreatable form of chronic pain known as erythromelagia, published in the Nov. 13, 2012, issue of Nature Communications, showed that it may be possible to predict whether a patient would respond positively to drug treatment. This led to Yale researchers looking into using this knowledge to help chronic pain patients.
Researchers at Yale found that, in theory those suffering with a particular mutation of chronic pain will respond to treatment with carbamazepine, which shows genomically-guided drug treatment for pain is not unrealistic, according to the report.
National Pain Institute Now Offers 25 Pain Management Treatments
Study: Sleeping Longer May Help Relieve Chronic Pain
Research into mutations in a rare, agonizing and previously thought untreatable form of chronic pain known as erythromelagia, published in the Nov. 13, 2012, issue of Nature Communications, showed that it may be possible to predict whether a patient would respond positively to drug treatment. This led to Yale researchers looking into using this knowledge to help chronic pain patients.
Researchers at Yale found that, in theory those suffering with a particular mutation of chronic pain will respond to treatment with carbamazepine, which shows genomically-guided drug treatment for pain is not unrealistic, according to the report.
More Articles on Pain Management:
Dr. Soloman Kamson to Head New Society for Advanced Spinal InterventionNational Pain Institute Now Offers 25 Pain Management Treatments
Study: Sleeping Longer May Help Relieve Chronic Pain